SCHEMBL7815358

SCHEMBL7815358

O=C1c2cccc(O)c2C(=O)c2sc(-c3ccccc3)nc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 6/20 0.58
TDO2 P48775 4/20 0.58
MAOA P21397 2/20 0.49
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
MAOB P27338 1/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
BACE1 P56817 2/20 0.47
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ELANE P08246 1/20 0.42
CTSG P08311 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7815486 0.85 IDO1 (0.57) IDO1TDO2ALDH1A1SMN1; SMN2MAPT
SCHEMBL7808047 0.84 IDO1 (0.79) IDO1TDO2ALDH1A1MEN1KMT2A
SCHEMBL7805816 0.82 IDO1 (0.53) IDO1TDO2ALDH1A1SMN1; SMN2LMNA
SCHEMBL7808401 0.80 IDO1 (0.57) IDO1TDO2ALDH1A1SMN1; SMN2MAPT
SCHEMBL7805503 0.79 MAOA (0.44) IDO1TDO2MAOAALDH1A1SMN1; SMN2
SCHEMBL7812573 0.76 IDO1 (0.53) IDO1TDO2ALDH1A1SMN1; SMN2LMNA
SCHEMBL22732884 0.76 IDO1 (0.63) IDO1TDO2ALDH1A1SMN1; SMN2MAPT
SCHEMBL7813200 0.74 MAOA (0.44) IDO1TDO2MAOAALDH1A1SMN1; SMN2
SCHEMBL7816954 0.74 IDO1 (1.00) IDO1TDO2ALDH1A1SMN1; SMN2MAPT
SCHEMBL8595445 0.73 IDO1 (0.82) IDO1TDO2TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 EP claimed
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 EP disclosed
US-6262095-B1 TREATMENT OF ILLNESS ASSOCIATED WITH AN ALTERATION IN VENOUS FUNCTION AND/OR INFLAMMATORY EDEMA LABORATOIRE INNOTHERA (FR) 2001-07-17 US disclosed